Arrowhead Pharmaceuticals
ARWR
$22.61
Share price
0.36%
Change (1 day)
-25.63%
Change (1 year)
Categories
Operating Margin for Arrowhead Pharmaceuticals (ARWR)
Operating Margin as of April 2024 (TTM): -71.00%
According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -71.00%. At the end of 2022 the company had an Operating Margin of -71.01%.
Operating Margin history for Arrowhead Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -71.01% | -30.28% |
| 2021 | -101.85% | 6% |
| 2020 | -96.09% | -338% |
| 2019 | 40.37% | -111.97% |
| 2018 | -337.30% | 208.16% |
| 2017 | -109.46% | -99.79% |
| 2016 | -51,613.12% | 114.45% |
| 2015 | -24,067.67% | -28.27% |
| 2014 | -33,554.35% | 207.22% |
| 2013 | -10,922.08% | -27.45% |
| 2012 | -15,054.05% | 407.47% |
| 2011 | -2,966.52% | 108.99% |
| 2010 | -1,419.46% | 171.48% |
| 2009 | -522.87% | -80.53% |
| 2008 | -2,685.89% | -14.5% |
| 2007 | -3,141.43% | -11.93% |
| 2006 | -3,567.11% | 125.04% |
| 2005 | -1,585.07% | 24.66% |
| 2004 | -1,271.56% | |
| 2002 | -10,865.27% | 444.49% |
| 2001 | -1,995.50% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -132.23% | 🇺🇸 USA |
 Moderna
MRNA | 5.44% | -107.66% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 17.06% | -124.03% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -61.01% | -14.07% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -108.63% | 53.00% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | -17,085.40% | 23,963.94% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.